Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIENCE Study

Int J Mol Sci. 2023 Jun 26;24(13):10647. doi: 10.3390/ijms241310647.

Abstract

Small extracellular vesicles (EVs) and their cargo are an important component of cell-to-cell communication in cardiac disease. Allogeneic adipose derived stem cells (ADSCs) are thought to be a potential approach for cardiac regenerative therapy in ischemic heart disease. The SCIENCE study investigated the effect of ADSCs administered via intramyocardial injection on cardiac function in patients with ischemic heart disease. The aim of this substudy, based on samples from 15 patients, was to explore small EV miRNA dynamics after treatment with ADSCs compared to a placebo. Small EVs were isolated at several timepoints after the percutaneous intramyocardial application of ADSCs. No significant effect of ADSC treatment on small EV concentration was detected. After 12 months, the expression of miR-126 decreased significantly in ADSC patients, but not in the placebo-treated group. However, all cardiac miRNAs correlated with plasma cardiac biomarkers. In line with the overall negative results of the SCIENCE study, with the exception of one miR, we did not detect any significant regulation of small EV miRNAs in this patient collective.

Keywords: adipose-derived stem cells; extracellular vesicles; ischemic heart disease; microRNA.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adipose Tissue
  • Extracellular Vesicles* / genetics
  • Heart Failure*
  • Humans
  • MicroRNAs* / genetics
  • Myocardial Ischemia* / genetics
  • Myocardial Ischemia* / therapy
  • Stem Cells

Substances

  • MicroRNAs